Johnson & Johnson (NY: JNJ )
163.61 +0.21 (+0.13%) Streaming Delayed Price Updated: 11:33 AM EST, Feb 8, 2023 Add to My Watchlist
Press Releases about Johnson & Johnson
MarketBeat Week in Review – 1/30 - 2/3
February 04, 2023
The markets are trending lower to end the week. It’s hard to figure out the markets after the blockbuster job report, but the MarketBeat team gave it a shot
Liposome Drug Delivery Market 2023 in-Depth Analysis, Growth, Size, Future Prospect, Regional Development and Global Outlook 2029
February 02, 2023
Liposome Drug Delivery Market Size, Share and Forecast 2023-2029 Key Players are – Ipsen Pharma, Celsion Corp, Gilead Sciences, Astellas Pharma, Johnson & Johnson, Luye Pharma Group, Novartis AG
Rancho Biosciences Welcomes BenevolentAI as New Member to Its Single Cell Data Science Consortium
February 01, 2023
SAN DIEGO, February 1, 2023 (Newswire.com) - On Feb. 26, 2022, Rancho Biosciences, a leading data sciences services company, launched its Single Cell Data Science (SCDS) pre-competitive consortium,...
Osteotomy Plates Market Share with Top Countries Data, Size, Global Industry Challenges, Business Overview and Forecast Research Study 2028
January 30, 2023
Osteotomy Plates SWOT Analysis Including Key Players - Arthrex, Acumed, Medartis, Johnson & Johnson, Group Fh Ortho, B. Braun Melsungen, Zimmer Biomet, Stryker Corporation, aap Implantate, Wright...
Topics Supply Chain
Exposures Supply Chain
Johnson & Johnson Reports Q4 and Full-Year 2022 Results
January 24, 2023
Drug Delivery Market – Major Technology Giants in Buzz Again : Johnson & Johnson, Sanofi, Pfizer
January 18, 2023
How to reach that market place and its associated audience with current marketing efforts? Benchmark now the competitive efforts with high growth emerging players and leaders of Drug Delivery Market.
Financial Resources Federal Credit Union Taps Scienaptic's Platform to Power its Credit Decisions With AI
January 11, 2023
NEW YORK - Jan. 11, 2023 - PRLog -- Leading global AI-powered credit decision platform provider, Scienaptic AI, announced today that Financial Resources Federal Credit Union has chosen to implement its...
Topics Artificial Intelligence
Exposures Artificial Intelligence
Johnson & Johnson Completes Acquisition of Abiomed
December 22, 2022
Johnson & Johnson Announces Extension of Abiomed Tender Offer to December 21, 2022
December 14, 2022
MarketBeat: Week in Review 12/05 – 12/09
December 10, 2022
The markets continue to have a lot to digest before there can be a Santa Claus raly. Here are some of the top stories our analysts were covering this week.
Johnson & Johnson to Participate in the 41st Annual J.P. Morgan Healthcare Conference
December 07, 2022
Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board
November 30, 2022
Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market?
November 16, 2022
Shares of AbbVie have been in rally mode since late October. The company has newer drugs whose revenue could make up for declines due to Humira's patent expiry.
Topics Intellectual Property
Exposures Intellectual Property
Via ACN Newswire